PF-Atlas › Clinical Trials › NCT02934698
An Efficacy and Safety Study of Ivacaftor in Patients With Cystic Fibrosis and Two Splicing Mutations
Ivacaftor · Phase 3
Registry ID
NCT02934698
Phase
Phase 3
Status
Completed
Drug / intervention
Ivacaftor
Sponsor
Medical University of South Carolina
Start
2016-11-01
Enrollment
2
About this trial
This postmarketing N of 2 study is designed to evaluate the efficacy and safety of open-label ivacaftor treatment in two sisters with cystic fibrosis and pancreatic sufficiency.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT02934698 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.